Biobizkaia
Ikerketa zentroa
University of Glasgow
Glasgow, Reino UnidoUniversity of Glasgow-ko ikertzaileekin lankidetzan egindako argitalpenak (32)
2024
-
Clinical and genetic characteristics of a large international cohort of individuals with rare NR5A1/SF-1 variants of sex development
eBioMedicine, Vol. 99
-
Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy—An observational Ponte di Legno Toxicity Working Group Study
British Journal of Haematology, Vol. 205, Núm. 4, pp. 1450-1459
2022
-
CT or Invasive Coronary Angiography in Stable Chest Pain
New England Journal of Medicine, Vol. 386, Núm. 17, pp. 1591-1602
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
-
The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?
World Journal of Emergency Surgery, Vol. 17, Núm. 1
-
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
BJS Open, Vol. 6, Núm. 1
2021
-
Clinical pre-test probability for obstructive coronary artery disease: insights from the European DISCHARGE pilot study
European Radiology, Vol. 31, Núm. 3, pp. 1471-1481
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia
The Lancet Haematology, Vol. 8, Núm. 7, pp. e513-e523
2020
-
Erratum: Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain (Health Qual Life Outcomes (2020) 18: 140 DOI: 10.1186/s12955-020-01312-4)
Health and Quality of Life Outcomes
-
Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain
Health and Quality of Life Outcomes, Vol. 18, Núm. 1
-
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
The Lancet, Vol. 396, Núm. 10262, pp. 1574-1584
-
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
The Lancet, Vol. 396, Núm. 10264, pp. 1745-1757
2019
-
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
The Lancet, Vol. 393, Núm. 10184, pp. 1937-1947
2017
-
Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial
European Radiology, Vol. 27, Núm. 7, pp. 2957-2968
-
Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1151-1210
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150
-
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015
The Lancet, Vol. 390, Núm. 10091, pp. 231-266